Your browser doesn't support javascript.
loading
Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia.
Bortnick, Eric M; Simma-Chiang, Vannita; Kaplan, Steven A.
Afiliación
  • Bortnick EM; Department of Urology, Mount Sinai Hospital, Icahn School of Medicine New York, NY.
  • Simma-Chiang V; Department of Urology, Mount Sinai Hospital, Icahn School of Medicine New York, NY.
  • Kaplan SA; Department of Urology, Mount Sinai Hospital, Icahn School of Medicine New York, NY.
Rev Urol ; 21(4): 154-157, 2019.
Article en En | MEDLINE | ID: mdl-32071563
Benign prostatic hyperplasia (BPH) is a common disease in men. Although transurethral resection of the prostate (TURP) is the gold standard therapy for treatment of BPH and associated lower urinary tract symptoms (LUTS), many patients choose to avoid surgery and instead choose medical therapy. Until recently, medical therapy for BPH has been thought to be both safe and effective. However, new studies have shown that some of these medications can have significant neurocognitive, psychiatric, and sexual side effects, including dementia and depression. As most patients taking these medications will continue them for the long term, it is vital for physicians to explain these potential risks to the patient prior to prescribing them for a quality-of-life condition.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Rev Urol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Rev Urol Año: 2019 Tipo del documento: Article